BRIEF-Jazz Pharmaceuticals comments on FDA nod for generic version of Xyrem
January 18, 2017 at 06:24 AM EST
* Jazz Pharmaceuticals says it will evaluate FDA's waiver of requirement for a single, shared system rems in connection with approval of a generic version of Xyrem
